RhumbLine Advisers’s Transmedics TMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.5M | Buy |
93,217
+3,693
| +4% | +$495K | 0.01% | 960 |
|
|
2025
Q1 | $6.02M | Sell |
89,524
-537
| -0.6% | -$36.1K | 0.01% | 1260 |
|
|
2024
Q4 | $5.62M | Buy |
90,061
+23,742
| +36% | +$1.48M | 0.01% | 1367 |
|
|
2024
Q3 | $10.4M | Buy |
66,319
+18,674
| +39% | +$2.93M | 0.01% | 1026 |
|
|
2024
Q2 | $7.18M | Buy |
47,645
+1,783
| +4% | +$269K | 0.01% | 1189 |
|
|
2024
Q1 | $3.39M | Buy |
45,862
+301
| +0.7% | +$22.3K | ﹤0.01% | 1621 |
|
|
2023
Q4 | $3.6M | Sell |
45,561
-1,034
| -2% | -$81.6K | ﹤0.01% | 1602 |
|
|
2023
Q3 | $2.55M | Buy |
46,595
+1,123
| +2% | +$61.5K | ﹤0.01% | 1743 |
|
|
2023
Q2 | $3.82M | Buy |
45,472
+3,016
| +7% | +$253K | ﹤0.01% | 1540 |
|
|
2023
Q1 | $3.22M | Buy |
42,456
+2,421
| +6% | +$183K | ﹤0.01% | 1568 |
|
|
2022
Q4 | $2.47M | Buy |
40,035
+3,852
| +11% | +$238K | ﹤0.01% | 1674 |
|
|
2022
Q3 | $1.51M | Buy |
36,183
+5,234
| +17% | +$218K | ﹤0.01% | 1928 |
|
|
2022
Q2 | $973K | Buy |
30,949
+5,744
| +23% | +$181K | ﹤0.01% | 2156 |
|
|
2022
Q1 | $679K | Buy |
25,205
+1,621
| +7% | +$43.7K | ﹤0.01% | 2283 |
|
|
2021
Q4 | $452K | Sell |
23,584
-371
| -2% | -$7.11K | ﹤0.01% | 2550 |
|
|
2021
Q3 | $793K | Buy |
23,955
+1,166
| +5% | +$38.6K | ﹤0.01% | 2339 |
|
|
2021
Q2 | $756K | Sell |
22,789
-651
| -3% | -$21.6K | ﹤0.01% | 2371 |
|
|
2021
Q1 | $973K | Sell |
23,440
-886
| -4% | -$36.8K | ﹤0.01% | 2201 |
|
|
2020
Q4 | $484K | Buy |
24,326
+2,804
| +13% | +$55.8K | ﹤0.01% | 2457 |
|
|
2020
Q3 | $297K | Buy |
21,522
+214
| +1% | +$2.95K | ﹤0.01% | 2524 |
|
|
2020
Q2 | $382K | Buy |
21,308
+8,080
| +61% | +$145K | ﹤0.01% | 2454 |
|
|
2020
Q1 | $160K | Buy |
13,228
+2,371
| +22% | +$28.7K | ﹤0.01% | 2655 |
|
|
2019
Q4 | $206K | Buy |
+10,857
| New | +$206K | ﹤0.01% | 2736 |
|